Positive result come out of Ibrance's Phase 3 PALOMA-2 trial and is now expected to make huge profit for Pfizer in the future. Pfizer Incorporation's cancer treatment drug, Ibrance got positive results out of Phase 3 PALOMA-2 trial, the an…
Quote saved.
Login to quote this blog
Failed to save quote. Please try again later.
You cannot quote because this article is private.